(Q57765005)

10

0 references

Lorenzo Lo Muzio

object named as

Lorenzo Lo Muzio

4

0 references

Angela Santoro

object named as

Angela Santoro

3

1 reference

ORCID Public Data File 2021

author name string

Rosanna Zamparese

1

0 references

Giuseppe Pannone

2

0 references

Fabrizio Corsi

5

0 references

Maria C. Pedicillo

6

0 references

Ester L. Scillitani

7

0 references

Simona Tortorella

8

0 references

Stefania Staibano

9

0 references

Pantaleo Bufo

12

0 references

publication date

January 2008

0 references

published in

Cancer Investigation

0 references

volume

26

0 references

issue

9

0 references

page(s)

929-935

0 references

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Prognostic factors of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

IAP family proteins--suppressors of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

The molecular basis and potential role of survivin in cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Prognostic significance of morphologic parameters in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Differential subcellular localization of functionally divergent survivin splice variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Expression of survivin and clinical correlation in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Survivin expression in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802017553